U.S. Energy Department assesses with ‘low confidence’ COVID may have originated from Chinese lab leak

U.S. Energy Department assesses with ‘low confidence’ COVID may have originated from Chinese lab leak


Epidemic-prevention workers in protective suits line up to get swab tested as outbreaks of coronavirus disease (COVID-19) continue in Beijing, China November 28, 2022. 

Thomas Peter | Reuters

WASHINGTON — The Energy Department concluded with “low confidence” that the Covid-19 pandemic “likely” originated from a laboratory leak in Wuhan, China, according to a classified report delivered to key lawmakers on the House and Senate Intelligence Committees, two sources with direct knowledge told NBC News.

Key lawmakers on the intelligence committees were briefed last month by the Office of the Director of National Intelligence about the classified report, the sources said.

The news was first reported by The Wall Street Journal on Sunday.

However, one source cautioned to NBC News that the DOE’s conclusion was not being viewed as hugely significant among the intelligence community due to interagency disagreements about Covid’s origins.

A Department of Energy spokesperson told NBC News that the agency “continues to support the thorough, careful, and objective work of our intelligence professionals in investigating the origins of COVID-19, as the President directed.”

Sen. Dan Sullivan, R-Alaska, on Sunday called for “extensive public hearings” if the U.S. intelligence community conclusively determines that Covid-19 leaked from a Chinese laboratory.

Asked on NBC News’ “Meet the Press” about what the consequences should be if the U.S. makes that determination and then discovers it was covered up by the Chinese government, Sullivan said that lawmakers must first “have public hearings on this and really dig into it.”

“Think about what just happened over the last three years, one of the biggest pandemics in a century. A lot of evidence that it’s coming from the Chinese,” Sullivan said. 

China has denied that Covid originated from a laboratory leak, previously calling the theory a “conspiracy.”

House Republicans have kicked off their own investigations into the origins of the pandemic.

The ODNI responded to a Feb. 13 letter from Reps. James Comer, chair of the Oversight Committee, and Brad Wenstrup, chair of the Select Subcommittee on the Coronavirus Pandemic, requesting “information about the origins of COVID-19,” a spokesperson for the Oversight Committee told NBC News Sunday. The committee is “reviewing the classified information provided,” the spokesperson said.

The White House referred NBC News to ODNI for comment.

Asked about the classified report on Sunday, White House national security adviser Jake Sullivan said that “there is not a definitive answer” from the intelligence community on the origins of Covid.

“There is a variety of views in the intelligence community. Some elements of the intelligence community have reached conclusions on one side, some on the other. A number of them have said they just don’t have enough information to be sure,” Jake Sullivan said on CNN’s “State of the Union.”

“If we gain any further insight or information, we will share it with Congress, and we will share it with the American people,” Jake Sullivan added. “But right now, there is not a definitive answer that has emerged from the intelligence community on this question.”



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More